Literature DB >> 2147560

Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats.

P Delatour1, E Benoit, M Caude, A Tambute.   

Abstract

The prochiral anthelmintic drug albendazole was administered orally to sheep and rats. Blood samples were taken at standardized intervals during the time course of the plasma kinetics: 18 h in rats and 48 h in sheep. The enantiomeric ratio of the sulfoxide metabolite was determined by means of HPLC on a chiral stationary phase, the chiral selector of which was a N-3,5-dinitrobenzoyl derivative of (S)-tyrosine. Two enantiomers were detected in both animal species but their ratios were inverted in rat vs. sheep. The evolution of the ratio is turned from a racemate at 15 min to 60(-):40(+) at 12 h in rats, while it moved from 23(-):77(+) at 3 h to 4(-):96(+) at 36 h after administration in sheep.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147560     DOI: 10.1002/chir.530020306

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  8 in total

1.  Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.

Authors:  E A Formentini; N Mestorino; J O Errecalde
Journal:  Vet Res Commun       Date:  2005-10       Impact factor: 2.459

2.  Efficacy of albendazole and mebendazole against Hymenolepis microstoma and Hymenolepis diminuta.

Authors:  R O McCracken; K B Lipkowitz; N O Dronen
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

3.  Enantiomerical pharmacokinetic prevalence of (+) albendazole sulphoxide in Trichinella spiralis muscle larvae.

Authors:  Juan José García-Rodríguez; María Carmen Del Vegas-Sánchez; Juan José Torrado-Durán; Francisco Bolás-Fernández
Journal:  Parasitol Res       Date:  2011-08-16       Impact factor: 2.289

4.  Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.

Authors:  B P Capece; G Castells; F Pérez; M Arboix; C Cristòfol
Journal:  Vet Res Commun       Date:  2000-07       Impact factor: 2.459

5.  Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.

Authors:  O M Takayanagui; P S Bonato; S A C Dreossi; V L Lanchote
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

6.  Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.

Authors:  H Solana; S Scarcella; G Virkel; C Ceriani; J Rodríguez; C Lanusse
Journal:  Vet Res Commun       Date:  2008-08-26       Impact factor: 2.459

7.  Comparison of Albendazole Cytotoxicity in Terms of Metabolite Formation in Four Model Systems.

Authors:  Lidia Radko; Maria Minta; Piotr Jedziniak; Sylwia Stypuła-Tręba
Journal:  J Vet Res       Date:  2017-09-19       Impact factor: 1.744

8.  Improvement of Albendazole Bioavailability with Menbutone Administration in Sheep.

Authors:  Raquel Diez; M Jose Diez; Juan J Garcia; Jose M Rodríguez; Cristina Lopez; Nelida Fernandez; Matilde Sierra; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2022-02-14       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.